Business Context and Reporting Period
Company: Coherus BioSciences, Inc.
Filing Type: Form 8-K (Current Report)
Date: May 11, 2016
Event: Regulation FD Disclosure regarding an investor presentation prepared for the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of an investor presentation containing operational and developmental information.
Material Changes
No material financial changes versus prior periods are reported in this document. The filing discloses the intent to present operational information and developmental plans to investors and analysts.
Guidance, Outlook, and Risks
- Management Commentary: The Company prepared an investor presentation with operational information and developmental plans.
- Legal Status of Information: The information disclosed under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
- Incorporation by Reference: The information shall not be deemed incorporated by reference into any other filing under the Exchange Act or the Securities Act of 1933.
Key Facts for Investor Verification
- Verify the content of the investor presentation (Exhibit 99.1) for specific operational data and developmental plans, as the 8-K text itself contains no numerical data.
- Note that the disclosed information is not legally "filed" and carries different liability standards than standard financial reports.
- Confirm the date of the presentation delivery at the Bank of America Merrill Lynch Health Care Conference (May 11, 2016).